The relationship between reduced YKL-40 expression and increased T-cell CD4 memory resting infiltration suggests that low CHI3L1 levels in colorectal cancer may be associated with a more favorable immune microenvironment for immunotherapy, as increased T-cell CD4 memory resting infiltration can enhance the immune system’s ability to attack cancer cells. This evidence concerns the gene CHI3L1 and cancer.